The Real World Study of Pyrotinib in the Treatment of Advanced Breast Cancer With HER2 Positive
NCT06495541
·
clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
500
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
RWS
Pyrotinib
Interventions
DRUG:
Pyrotinib
Sponsor
Tianjin Medical University Cancer Institute and Hospital